Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Oil prices fall below 100 yuan+Besent calls out, U.S. Treasury yields retreat from 2002 highs

Oil prices fall below 100 yuan+Besent calls out, U.S. Treasury yields retreat from 2002 highs

智通财经智通财经2026/10/06 11:30
Show original

U.S. Treasury yields have retreated from their highest levels since 2002.

According to Zhihui Finance APP, U.S. Treasury yields have retreated from their highest levels since 2002, as oil prices fell below $100 per barrel and U.S. Treasury Secretary Scott Besant insisted that the government debt burden is manageable. The yields on 10-year and 30-year U.S. Treasury bonds dropped by 3 and 4 basis points, to 5.27% and 5.63% respectively, while the 2-year yield remained largely unchanged. On Tuesday, oil prices declined as signs emerged that more crude oil is being supplied through the Strait of Hormuz.

This signals a pause in the global bond market sell-off, which previously continued due to concerns over inflation triggered by conflict between the U.S. and Iran, and a rising expectation of further monetary tightening by the Federal Reserve.

Oil prices fall below 100 yuan+Besent calls out, U.S. Treasury yields retreat from 2002 highs image 0

Besant attempted to reassure investors, stating that a combination of economic growth and spending restrictions will “soon” begin to change the U.S. government’s borrowing trajectory. In a fireside chat in Pennsylvania on Monday evening, he said the government would start “reversing this trend.”

Voices of Doubt: Deficit Unsolved, Reassurance Falls Short

Nevertheless, the market remains skeptical of Besant’s statements and is reluctant to declare that the bond market sell-off has ended.

Macquarie strategist Gareth Berry commented: “Given the deficit is as high as 6% and there are no plans to cut the deficit, the market may remain very doubtful. Speaking about targets is not the same as having a plan.”

Schroders fund manager James Ling said he is focused not only on crude prices. “To see a meaningful rebound across the entire curve, the primary condition is for energy prices to start falling,” he said. “It’s not just about crude oil prices, but also refined product prices.”

Additionally, Bridgewater founder Ray Dalio warned that the U.S. is approaching the limit of the debt cycle and, if spending continues to exceed earnings, may face a crisis within three years. He said U.S. Treasuries are vulnerable to decreased demand from China and Japan (the two largest foreign holders of U.S. debt).

However, HSBC strategists believe the market’s bet on roughly 80 basis points of Federal Reserve rate hikes by 2027 is “excessive,” but they still maintain that the yield spread between 5-year and 30-year U.S. Treasuries will widen. HSBC U.S. rates strategist Dheeraj Narula wrote in a report: “We believe that surging volatility, combined with historical data showing a lack of clear technical resistance at these levels, has led many investors to adopt a wait-and-see stance, although the appeal of higher long-term yields is increasingly evident.”

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ-BridgeBio shares rise as FDA initiates priority review for dwarfism drug

On October 6th, shares of pharmaceutical company BridgeBio Pharma (BBIO.O) rose 2.5% in pre-market trading to $67.80. The company announced that the U.S. Food and Drug Administration (FDA) has granted priority review to its application seeking approval for the investigational oral drug infigratinib for the treatment of children with achondroplasia, the most common type of dwarfism. The FDA has set a target decision date of February 4, 2027. The application is based on a late-stage clinical trial that met both primary and key secondary endpoints; children treated with infigratinib experienced an adjusted annual growth velocity 1.74 centimeters greater than those given placebo. The drug also improved arm span and body proportions in children under eight years old. No serious adverse events or discontinuations related to the drug were reported. BridgeBio plans to apply for European approval in the fourth quarter of 2026. As of the close of the previous trading day, BBIO shares are down 13.5% year-to-date. (For the convenience of non-English speakers, Reuters has automated this report into several other languages. Because automated translation may contain errors or lack required context, Reuters does not guarantee the accuracy of automated translation, which is provided for readers’ convenience only. Reuters accepts no liability for any damages or losses arising from the use of automated translation.)

路透社•2026/10/06 12:17

Google (GOOGL.US) spends $4.3 billions on electricity, securing 3,590 megawatts of long-term energy from Constellation Energy (CEG.US).

Google has signed a 3,590 MW power purchase agreement with Constellation Energy, with a quarter of the electricity coming from nuclear power, involving an investment of $4.3 billion.

智通财经•2026/10/06 12:12

BUZZ - Torm shares decline as Oaktree exits in a $253.5 million secondary offering

Updated Pricing Details: On October 6th, before the market opened on Tuesday, shares of the tanker operator Torm (TRMD.O), listed in the US, dropped 3.2% to $39.72 after the company announced the pricing of its secondary offering. According to the company (link), funds managed by Oaktree Capital Management sold approximately 6.3 million shares, raising a total of about $253.5 million. The secondary offering was priced at $40.05 per share, a 2.4% discount to the stock's previous closing price. According to the prospectus, Oaktree Capital completely exited its remaining approximately 6.2% stake following the sale (link). JPMorgan served as the sole underwriter for this issuance. Last month, Oaktree Capital (link) sold shares in another secondary offering of 9 million shares at $32.25 per share. Driven by record freight rates, the shares of tankers listed in Northern Europe (link) have soared, and Torm's stock closed up 2.6% on Monday at $41.05. As of Monday’s close, the company’s US-listed shares had surged about 110% year-to-date, including a 47% gain over the past three months. (For the convenience of non-English speakers, Reuters provides its report with automated translation into several languages. Due to the possibility of errors or the lack of contextual accuracy from automated translation, Reuters does not guarantee the accuracy of these texts. The automated translation is provided for readers’ convenience only. Reuters accepts no liability for any damage or loss arising from the use of automated translation features.)

路透社•2026/10/06 12:11

BRIEF-Lamb Weston Holdings Announces Quarterly Dividend

Lamb Weston Holdings, Inc. LW.N: LAMB WESTON HOLDINGS ANNOUNCES QUARTERLY DIVIDEND LAMB WESTON HOLDINGS - DECLARES QTRLY DIVIDEND OF $0.38 PER SHARE Source text: ID:nBwWVH9na Further company coverage: LW.N

Reuters•2026/10/06 11:56